Clover Health Investments, Corp.
(NASDAQ) CLOV
Clover Health Investments, Corp. Financials at a Glance
Market Cap
$1.87B
Revenue (TTM)
$2.21B
Net Income (TTM)
$56.94M
EPS (TTM)
$-0.11
P/E Ratio
-31.61
Dividend
$0.00
Beta (Volatility)
1.57 (High)
Dividend
$0.00
Beta (Volatility)
1.57 (High)
Price
$3.55
Volume
4,739,402.423
Open
$3.59
Price
$3.55
Volume
4,739,402.423
Open
$3.59
Previous Close
$3.55
Daily Range
$3.54 - $3.69
52-Week Range
$1.58 - $3.92
Dividend
$0.00
Beta (Volatility)
1.57 (High)
Price
$3.55
Volume
4,739,402.423
Open
$3.59
Previous Close
$3.55
Daily Range
$3.54 - $3.69
52-Week Range
$1.58 - $3.92
CLOV News
CLOV: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Clover Health Investments, Corp.
Industry
Healthcare Providers and Services
Sector
Health CareEmployees
724
CEO
Andrew Toy
Website
www.cloverhealth.comHeadquarters
Franklin, TN 37067, US
CLOV Financials
Key Financial Metrics (TTM)
Gross Margin
18%
Operating Margin
-3%
Net Income Margin
-3%
Return on Equity
-17%
Return on Capital
-16%
Return on Assets
-8%
Earnings Yield
-3.16%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$1.87B
Shares Outstanding
526.68M
Volume
4.74M
Avg. Volume
6.25M
Financials (TTM)
Gross Profit
$355.88M
Operating Income
$85.53M
EBITDA
$83.86M
Operating Cash Flow
$66.93M
Capital Expenditure
$2.04M
Free Cash Flow
$68.98M
Cash & ST Invst.
$95.35M
Total Debt
$0.00
Clover Health Investments, Corp. Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$749.19M
+62.0%
Gross Profit
$159.54M
+46.5%
Gross Margin
21.30%
N/A
Market Cap
$1.87B
N/A
Market Cap/Employee
$3.28M
N/A
Employees
570
N/A
Net Income
$27.33M
+2245.5%
EBITDA
$27.85M
+3546.7%
Quarterly Fundamentals
Net Cash
$177.56M
+10.9%
Accounts Receivable
$202.69M
+46.6%
Inventory
$0.00
N/A
Long Term Debt
$0.00
N/A
Short Term Debt
$0.00
N/A
Return on Assets
-8.16%
N/A
Return on Invested Capital
-15.76%
N/A
Free Cash Flow
$107.04M
+749.6%
Operating Cash Flow
$107.89M
+762.2%